John Paderi, John Paderi John Paderi
- Ihp Therapeutics, Inc. (no department on record)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
FY2023 NIH rank #1,100
- Top 10% Funded
- Early Career
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2023 onlyCareer claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
NIH Funding · FY2023
Linked Award Amount
$4M
Full award amounts, FY2023
Award Records
3
Records listing this PI
Award-Linked Rank
#1,100
By linked amount among FY2023 PIs
Earliest Year Loaded
2023
ScienceDex PI coverage
Award data coverage
ScienceDex currently has one fiscal year of PI ranking data for this record. This does not establish the first NIH award or current employer.
Single fiscal year on record (FY2023): $4M in linked award amounts across 3 award records · Award-linked rank #1100.
FY2023 award records by amount
NIH award records listing John Paderi, John Paderi John Paderi as a PI. Multi-PI records show the full award amount for context.
- 1UG3NS134781-01UG3Contact PIA novel glycan-based selectin and complement inhibitor for at-home disease-modifying rescue of pain crisis in sickle cell disease$2.6Maward amount
- 4R44HL167473-02R44Contact PIDevelopment of a novel disease-modifying glycan therapeutic for early at-home intervention of acute vaso-occlusive crisis in sickle cell disease$1.1Maward amount
- 1R44HL167473-01R44Contact PIDevelopment of a novel disease-modifying glycan therapeutic for early at-home intervention of acute vaso-occlusive crisis in sickle cell disease$301.5Kaward amount
Award organization
Organizations that administered FY2023 awards listing John Paderi, John Paderi John Paderi as a PI.
FY2023 award administered by Ihp Therapeutics, Inc. (CA).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2023First NIH AwardIhp Therapeutics, Inc.
- 2023$500K Cumulative Funding
- 2023$1M Cumulative Funding
- 2023$2M Cumulative Funding
- 2023Entered Top 50% NationallyRanked #1100
- 2023Entered Top 25% NationallyRanked #1100
- 2023Entered Top 10% NationallyRanked #1100